WOEST supports clopidogrel only in PCI patients on anticoagulation
Publication of the WOEST trial results reaffirm the study’s major finding that antiplatelet therapy with clopidogrel alone is preferable to the use of both aspirin and clopidogrel in patients undergoing percutaneous coronary intervention who are receiving oral anticoagulant therapy. (Source: MedWire News - Cardiology)
Source: MedWire News - Cardiology - February 25, 2013 Category: Cardiology Source Type: news

Volcano Reports Fourth Quarter Revenue Up 10%; Fractional Flow Reserve Revenue Up 45% for Year
Volcano Corporation (NASDAQ: VOLC) today reported its fourth quarter revenue which was $102.5 million, up 10% over the same period last year. Leading the increased revenue were disposables in Volcano's fractional flow reserve business, which were up 45% on an annual basis. While the adoption of FFR has lagged behind the clinical data, Volcano's reported 45% increase in revenue definitely points to increasing use of this technology to optimize stent placement and decision-making. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - February 22, 2013 Category: Cardiology Source Type: news

SIGN: Updated guideline on acute coronary syndromes
Source: SIGN Area: Evidence> Guidelines The Scottish Intercollegiate Guidelines Network (SIGN) has updated its 2007 clinical guideline on the in-hospital management of patients with an acute coronary syndrome (Guideline no:93).   The updated guideline contains a revised recommendation around optimal timing for delivery of primary percutaneous coronary intervention, in line with new European consensus guidelines, and incorporates two new good practice points.   See link below for further details. (Source: NeLM - Cardiovascular Medicine)
Source: NeLM - Cardiovascular Medicine - February 20, 2013 Category: Cardiology Source Type: news

Medtronic Drug-Eluting Stent Revenue Up 42%
Medtronic, Inc. (NYSE: MDT) today announced financial results for the third quarter of fiscal year 2013, which ended January 25, 2013. One of fastest growing segments of this $4 billion company was the coronary division which grew 19% overall. Fueled by sales of its Resolute Integrity Zotarolimus-eluting stent, approved last year in the U.S. and Japan, drug-eluting stent quarterly revenue was up 42% to $274 million. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - February 20, 2013 Category: Cardiology Source Type: news

Diabetes Patients Fare Better With CABG Than PCI Diabetes Patients Fare Better With CABG Than PCI
A new study comparing contemporary CABG surgery with angioplasty using the newest-generation drug-eluting stents in patients with diabetes and complex coronary disease finds that surgery is best, confirming data from FREEDOM and other prior trials. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 19, 2013 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

CABG best in diabetics with severe CAD in contemporary trial
A new study comparing contemporary CABG surgery with angioplasty using the newest-generation drug-eluting stents in patients with diabetes and complex coronary disease finds that surgery is best, confirming data from FREEDOM and other prior trials. (Source: theHeart.org)
Source: theHeart.org - February 18, 2013 Category: Cardiology Source Type: news

Can Renal Denervation Reduce Heart Attack, Stroke and Death?
Renal denervation, a catheter-based procedure designed to lower blood pressure, has been the subject of much interest to the interventional community over the past couple of years. Although high blood pressure puts one in three adults worldwide at risk of heart attack, stroke and kidney failure, the renal denervation studies that have been conducted to date have looked only at reducing blood pressure rather than the overall impact on major cardiac events. St. Jude's (NYSE:STJ) announcement today of the EnligHTNment trial is the first that will look at "hard end points" such as heart attack, stroke and mortality. ...
Source: News from Angioplasty.Org - February 15, 2013 Category: Cardiology Source Type: news

PCI by Radial Approach Feasible in Cardiogenic ShockPCI by Radial Approach Feasible in Cardiogenic Shock
Percutaneous coronary intervention (PCI) by the radial approach appears safe and feasible in patients with acute ST-elevation myocardial infarction (STEMI) and cardiogenic shock. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 15, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news

Medtronic Announces FDA Approval and Launch of Its Advisa MRI Pacemaker System
Medtronic, Inc. (NYSE: MDT), today announced FDA approval and U.S. launch of its Advisa DR MRI™ SureScan® pacing system. The Advisa MRI system is Medtronic's second-generation MR-Conditional pacemaker and is the first system to combine the most advanced pacing technology with proven MRI access. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - February 14, 2013 Category: Cardiology Source Type: news

For Diagnostic Cardiac Test, Mayo Clinic Physicians Take New Route to the Heart Through Wrist Artery
Cardiologists are performing angioplasties with a new procedure by accessing an artery in a patient's wrist rather than near the groin, eliminating potential complications that can occur in traditional catheterization. (Source: Mayo Clinic Jacksonville News)
Source: Mayo Clinic Jacksonville News - February 14, 2013 Category: Hospital Management Authors: Mayo Clinic Source Type: news

For Diagnostic Cardiac Test, Mayo Clinic Physicians Take New Route to the Heart Through Wrist Artery
Cardiologists are performing angioplasties with a new procedure by accessing an artery in a patient's wrist rather than near the groin, eliminating potential complications that can occur in traditional catheterization. (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 14, 2013 Category: Databases & Libraries Authors: Mayo Clinic Source Type: news

For Diagnostic Cardiac Test, Mayo Clinic Physicians Take New Route to the Heart Through Wrist Artery
Cardiologists are performing angioplasties with a new procedure by accessing an artery in a patient's wrist rather than near the groin, eliminating potential complications that can occur in traditional catheterization. (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - February 14, 2013 Category: Research Authors: Mayo Clinic Source Type: news

RCT: Clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention (WOEST)
Source: Lancet Area: News If percutaneous coronary intervention (PCI) is required in patients taking oral anticoagulants, double antiplatelet therapy with aspirin and clopidogrel is indicated. However, such triple therapy increases the risk of serious bleeding and this treatment strategy has not been tested prospectively.   Omission of oral anticoagulants could lead to an increased risk of thrombotic stroke, whereas clopidogrel is essential to prevent stent thrombosis. The exclusion of aspirin might, therefore, be useful to reduce the bleeding risk in patients with coronary artery disease.   The open-lab...
Source: NeLM - News - February 13, 2013 Category: Drugs & Pharmacology Source Type: news

Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2013
Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the third quarter of its fiscal year 2013 on Tuesday, February 19, 2013. A news release will be issued at approximately 6:15 a.m. Central Time and will be available at www.medtronic.com/newsroom. The earnings news release will include summary financial information for Medtronic's third quarter, which ended January 25, 2013. Medtronic will host a webcast at 7 a.m. Central Time to discuss financial results for its third quarter. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - February 12, 2013 Category: Cardiology Source Type: news

Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
Volcano Corporation (Nasdaq: VOLC) today announced it will report its operating results for the fourth quarter of fiscal 2012 on Thursday, February 21. The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 2 p.m., Pacific Standard Time (5 p.m., Eastern Standard Time), Thursday, February 21. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - February 11, 2013 Category: Cardiology Source Type: news

NICE consults on draft guideline on treatment of acute myocardial infarction
Source: NICE Area: News NICE has issued a draft guideline for public consultation on the acute management of myocardial infarction with ST-segment-elevation (STEMI). The draft guideline is open to comments from stakeholders up until Friday 22nd March.   The draft key recommendations include the following:   . All people with acute STEMI are immediately assessed for their eligibility for coronary reperfusion therapy (either primary percutaneous coronary intervention (PPCI) or fibrinolysis). . Do not use level of consciousness after cardiac arrest caused by suspected acute STEMI to determine wh...
Source: NeLM - Cardiovascular Medicine - February 8, 2013 Category: Cardiology Source Type: news

Heart Protected When Chest Pain Experienced Prior To Heart Attack
Patients who experience chest pain in the 24 hours preceding a heart attack, also called preinfarction angina, have smaller heart attacks and improved cardiac function in the contemporary cardiac stenting era, researchers found in a study published in Circulation: Cardiovascular Interventions. "Even before we began treating heart attack patients with angioplasty and stenting, physicians recognized that patients with chest pain prior to their heart attack seem to have better outcomes," says the study's senior author, Jay H... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 7, 2013 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

St. Jude Begins Expanded Renal Denervation Study
St. Jude Medical has announced enrollment of the first patient in the EnligHTN II trial, a post-market clinical study that will further evaluate the safety and efficacy of the EnligHTN™ Renal Denervation System in patients with uncontrolled hypertension. Building on results from the initial EnligHTN study of 46 patients, this expanded study will enroll 500 patients in 40 centers throughout Europe and Australia with five year follow-up. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - February 7, 2013 Category: Cardiology Source Type: news

Novel Catheter-Based Treatment for Heart Failure Begins U.S. Trial
CardioKinetix, Inc., a medical device company, based in Menlo Park, California, recently announced the start of a major U.S.-based trial for their Parachute™ Ventricular Partitioning Device, the first catheter-based treatment for heart failure. Implanted in a procedure similar to coronary angioplasty and stents, initial smaller trials for the device have shown positive results at two and three years. As a result of this data, the Parachute currently is approved for use in Europe and carries the CE Mark. The PARACHUTE IV Trial expects to enroll 478 patients in the U.S. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - February 6, 2013 Category: Cardiology Source Type: news

Consensus move promotes radial access for coronary intervention
A European consensus document aims to encourage interventionalists to choose radial artery over femoral artery access where possible when performing percutaneous coronary intervention. (Source: MedWire News - Cardiology)
Source: MedWire News - Cardiology - February 4, 2013 Category: Cardiology Source Type: news

Direct Healthcare Professional Communication on approved dosing regimens for bivalirudin (Angiox®) following reports of inappropriate use
Source: MHRA Area: News The Medicines Company has issued a Direct Healthcare Professional Communication regarding bivalirudin (Angiox®, which states that the approved dosing regimen for patients undergoing percutaneous coronary intervention (PCI) must be followed (i.e. an IV bolus injection of 0.75 mg/kg body weight should be followed immediately by an IV infusion at 1.75 mg/kg/hour for at least the duration of the PCI).   Post-marketing data suggest that some patients are only treated with an IV bolus dose of bivalirudin, without the required subsequent IV infusion. Due to the short half-life of bivalirudin ...
Source: NeLM - Cardiovascular Medicine - February 4, 2013 Category: Cardiology Source Type: news

Volcano Announces New iPad Teaching Application for Its Recently-Released Visions® PV .035 Digital IVUS Catheter
Volcano Corporation (Nasdaq: VOLC) today announced it has a new interactive educational tool to facilitate learning about IVUS-guided interventional procedures with its new Visions® PV .035 Digital IVUS Catheter. The new Aortic IVUS App for iPad, available on the Apple App Store, provides case examples with interactive education on the procedural workflow and image interpretation, and is intended for healthcare professionals involved in endovascular aortic procedures. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - February 1, 2013 Category: Cardiology Source Type: news

Report Invaluable To All Those Involved In Planning, Managing And Delivering Percutaneous Coronary Interventional Procedures
The 2011 annual report of the National Audit of Percutaneous Coronary Intervention (PCI) highlights the significant progress within hospitals to expand PCI services to treat more patients with acute coronary syndromes. PCI mechanically improves blood flow to the heart and can be used to relieve the symptoms of angina, prevent and treat heart attacks. When used to treat heart attack patients, the procedure is called primary PCI... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 30, 2013 Category: Consumer Health News Tags: Heart Disease Source Type: news

UK Catches Up With Europe in PCI StakesUK Catches Up With Europe in PCI Stakes
New audit figures from the UK show that the country is catching up with its European neighbors in performing PCIs. Primary angioplasty is now the treatment of choice for STEMI, and radial access is the preferred route for PCI procedures, the report shows. Heartwire (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 30, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news

UK catches up with Europe in PCI stakes
New audit figures from the UK show that the country is catching up with its European neighbors in performing PCIs. Primary angioplasty is now the treatment of choice for STEMI, and radial access is the preferred route for PCI procedures, the report shows. (Source: theHeart.org)
Source: theHeart.org - January 29, 2013 Category: Cardiology Source Type: news

Radial Access 1st Choice for PCI, ESC Says (CME/CE)
(MedPage Today) -- Radial access should be the initial choice for percutaneous coronary intervention, saving femoral access for bailout, according to a consensus document from the European Society of Cardiology. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - January 28, 2013 Category: Cardiology Source Type: news

Medtronic Launches Lower-Extremity Indication for Complete 'SE' Vascular Stent Internationally
Expanding its role in the treatment of peripheral artery disease, Medtronic, Inc. (NYSE: MDT) today announced the CE (Conformité Européene) mark and international launch of its Complete SE (self-expanding) vascular stent for use in the lower extremities –– specifically, the superficial femoral arteries (SFA) and proximal popliteal arteries (PPA), which supply blood to the legs. In the U.S., the Complete SE stent is approved by the FDA only for use in the iliac arteries. Its use in lower-extremity arteries in the United States is under review by the FDA. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - January 28, 2013 Category: Cardiology Source Type: news

Fewer Spontaneous MIs After PCI Vs Medical TherapyFewer Spontaneous MIs After PCI Vs Medical Therapy
Compared with optimal medical therapy, percutaneous coronary intervention (PCI) cuts rates of spontaneous myocardial infarction (MI) afterward - but it doesn't offer much else in the way of advantages, researchers say. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 25, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news

AngioScore Launches New 100 mm Length AngioSculpt(R) Scoring Balloons For Treatment of Peripheral Artery Disease Below The Knee (BTK)
FREMONT, Calif.--(Healthcare Sales & Marketing Network)--AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, today announced the launch of its new 100 mm length AngioSculpt PTA Scoring Balloon Ca... Devices, InterventionalAngioScore, AngioSculpt, Scoring Balloon Catheter, peripheral artery disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 25, 2013 Category: Pharmaceuticals Source Type: news

AngioScore Launches New 100 mm Length AngioSculpt Scoring Balloons For Treatment Of Peripheral Artery Disease Below The Knee (BTK)
AngioScore, Inc.,a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, recently announced the launch of its new 100 mm length AngioSculpt PTA Scoring Balloon Catheters for the treatment of peripheral artery disease (PAD) below the knee (BTK) (Source: Medical Design Online News)
Source: Medical Design Online News - January 25, 2013 Category: Medical Equipment Source Type: news

Medtronic Drug-Eluting Balloon Study Completes Enrollment
Medtronic, Inc. (NYSE: MDT), today announced completion of enrollment in IN.PACT SFA II, the U.S. arm of its clinical study for the IN.PACT Admiral drug-eluting balloon as a treatment for peripheral artery disease in the superficial femoral and proximal popliteal arteries (SFA and PPA). Results of IN.PACT SFA II will be combined with those from IN.PACT SFA I, which previously completed enrollment of 150 patients in Europe, to support a premarket approval (PMA) application to the U.S. Food and Drug Administration (FDA). (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - January 23, 2013 Category: Cardiology Source Type: news

Drug-Eluting Balloon: Best Option for in-Stent Restenosis?Drug-Eluting Balloon: Best Option for in-Stent Restenosis?
The first meta-analysis to compare drug-eluting balloons with drug-eluting stents or plain angioplasty for in-stent restenosis indicates that the balloon comes out best. Guidelines should be changed accordingly, say the researchers, but others say this conclusion is premature. Heartwire (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 23, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news

Drug-eluting balloon: Best option for in-stent restenosis?
The first meta-analysis to compare drug-eluting balloons with drug-eluting stents or plain angioplasty for in-stent restenosis indicates that the balloon comes out best. Guidelines should be changed accordingly, say the researchers, but others say this conclusion is premature. (Source: theHeart.org)
Source: theHeart.org - January 22, 2013 Category: Cardiology Source Type: news

Healthgrades names top hospitals
Healthgrades, an online healthcare quality reporting group, released its list of 262 hospitals it calls the best when rated for risk-adjusted mortality and complication rates for 27 common procedures and conditions involving (Source: Healthcare IT News)
Source: Healthcare IT News - January 16, 2013 Category: Information Technology Authors: Bernie Monegain Tags: Online Only angioplasty eligible hospitals Medicare Quality and Safety Source Type: news

Volcano Corporation Announces Record Preliminary Fourth Quarter 2012 Revenues
Volcano Corporation (Nasdaq: VOLC) said today that it expects total revenues for the fourth quarter of 2012 will be approximately $102.5 million, bringing expected full year 2012 revenues to approximately $381.9 million. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - January 15, 2013 Category: Cardiology Source Type: news

Research suggests optimal duration of dual antiplatelet therapy may vary depending on stent type
Source: Eur Heart J Area: News According to research published early online in the European Heart Journal, the optimal duration of dual antiplatelet therapy (DAPT) may differ depending on the type of stent implanted.   The authors note that this currently remains a controversial issue due to the lack of prospective, randomised data.  They conducted a pre-specified analysis of the PRODIGY study to assess device-specific outcomes relative to different duration of DAPT after everolimus- (EES), paclitaxel (PES), zotarolimus- (ZES-S) eluting, or bare metal stent (BMS) insertion.   The open-label PRODIGY ...
Source: NeLM - Cardiovascular Medicine - January 14, 2013 Category: Cardiology Source Type: news

Angioplasty Affords Symptom Relief for Patients With Multiple Sclerosis
Two studies suggest that for many people with MS, minimally invasive interventional radiology treatments--such as angioplasty for chronic cerebrospinal venous insufficiency--can provide effective palliative therapy. (Source: Consultant Live)
Source: Consultant Live - January 10, 2013 Category: Primary Care Source Type: news

Fibrinogen Level Tied to Poorer PCI Outcomes (CME/CE)
(MedPage Today) -- An elevated serum fibrinogen level predicted worse short-term ischemic outcomes among patients undergoing elective percutaneous coronary intervention after pretreatment with clopidogrel, researchers found. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - January 7, 2013 Category: Cardiology Source Type: news

Diabetics may do marginally better with drug-eluting stents
NEW YORK (Reuters Health) - After primary coronary angioplasty, diabetics have lower rates of target vessel revascularization if they received drug-eluting stents (DES) rather than bare metal stents (BMS), a new paper says. (Source: Modern Medicine)
Source: Modern Medicine - January 7, 2013 Category: Journals (General) Source Type: news

Stent placement ‘effective alternative to IVT in stroke patients’
In stroke patients in whom intravenous thrombolysis is either contraindicated or has failed, intra-arterial revascularization with cerebral angioplasty and stent placement is an effective and well-tolerated treatment, say Czech researchers. (Source: MedWire News - Thrombosis)
Source: MedWire News - Thrombosis - January 1, 2013 Category: Internal Medicine Source Type: news

Radial access for PCI doesn't boost neurologic complications
NEW YORK (Reuters Health) - Neurologic complications are not more frequent when percutaneous coronary intervention (PCI) is done with radial access, researchers from UK report. (Source: Modern Medicine)
Source: Modern Medicine - December 31, 2012 Category: Journals (General) Source Type: news

Stent placement ‘effective alternative to IVT in stroke patients’
In stroke patients in whom intravenous thrombolysis is either contraindicated or has failed, intra-arterial revascularization with cerebral angioplasty and stent placement is an effective and well-tolerated treatment, say Czech researchers. (Source: MedWire News - Thrombosis)
Source: MedWire News - Thrombosis - December 31, 2012 Category: Internal Medicine Source Type: news

Mustang® and JIVE PTCA Registered Successfully in Vietnam
(Source: Microport News Release)
Source: Microport News Release - April 30, 2012 Category: Medical Equipment Source Type: news

Mustang < sup > & reg; < /sup > and JIVE PTCA Registered Successfully in Vietnam
(Source: Microport News Release)
Source: Microport News Release - April 30, 2012 Category: Medical Equipment Source Type: news

Revised Spanish Article-Coronary Angioplasty
Coronary angioplasty is a procedure used to open narrow or blocked coronary arteries. (Source: National Heart, Lung, and Blood Institute Health Topics)
Source: National Heart, Lung, and Blood Institute Health Topics - March 21, 2012 Category: Consumer Health News Source Type: news

Revised Article-Coronary Angioplasty
Coronary angioplasty is a procedure used to open narrow or blocked coronary arteries. The procedure restores blood flow to the heart muscle. (Source: National Heart, Lung, and Blood Institute Health Topics)
Source: National Heart, Lung, and Blood Institute Health Topics - February 1, 2012 Category: Consumer Health News Source Type: news

New Spanish Article-Angioplasty (Angioplastia coronaria)
New Spanish language article on Angioplasty (Angioplastia coronaria). (Source: National Heart, Lung, and Blood Institute Health Topics)
Source: National Heart, Lung, and Blood Institute Health Topics - August 9, 2010 Category: Consumer Health News Source Type: news

Revised Article-Coronary Angioplasty
Coronary angioplasty is a procedure used to open blocked or narrowed coronary (heart) arteries. The procedure improves blood flow to the heart muscle. (Source: National Heart, Lung, and Blood Institute Health Topics)
Source: National Heart, Lung, and Blood Institute Health Topics - January 29, 2010 Category: Consumer Health News Source Type: news